ISSCR Statement Regarding the Marketing of Unproven Stem Cell Treatments for COVID-19
ISSCR has become aware of recent claims that stem cells can be used to treat people infected with COVID-19. While stem cell research shows promise for numerous diseases and conditions, there currently are no approved stem cell-based approaches for the prevention and treatment of COVID-19 infection.
ISSCR has become aware of recent claims that stem cells can be used to treat people infected with COVID-19. While stem cell research shows promise for numerous diseases and conditions, there currently are no approved stem cell-based approaches for the prevention and treatment of COVID-19 infection.
The ISSCR is a vocal and active opponent of the premature marketing and commercialization of stem cell therapies that have not been tested in rigorous clinical trials. The Society has released guidelines to help researchers and regulators navigate the translation of cellular therapies. The ISSCR’s public information website is aimed at helping patients, families, and the science-interested public learn about stem cells, better understand the current state of research, and make informed decisions about stem cell treatments.
ارسال به دوستان